Clinical profiles of chinese patients with diffuse panbronchiolitis by Hawkins, B et al.
Title Clinical profiles of chinese patients with diffuse panbronchiolitis
Author(s) Tsang, KWT; Ooi, CGC; Ip, MSM; Lam, WK; Ngan, H; Chan, EYT;Hawkins, B; Ho, CS; Amitani, R; Tanaka, E; Itoh, H
Citation Thorax, 1998, v. 53 n. 4, p. 274-280
Issued Date 1998
URL http://hdl.handle.net/10722/42673
Rights Creative Commons: Attribution 3.0 Hong Kong License
 1998;53;274-280 Thorax
  
Itoh 
T Chan, Brian Hawkins, Chu-shak Ho, Ryoichi Amitani, Eisaku Tanaka and Harumi 
Kenneth W T Tsang, Clara G C Ooi, Mary S M Ip, Wah-kit Lam, Henry Ngan, Eric Y
  
 panbronchiolitis
Clinical profiles of Chinese patients with diffuse
 http://thorax.bmj.com/cgi/content/full/53/4/274
Updated information and services can be found at: 
 These include:
 References
 http://thorax.bmj.com/cgi/content/full/53/4/274#otherarticles
5 online articles that cite this article can be accessed at: 
  
 http://thorax.bmj.com/cgi/content/full/53/4/274#BIBL
This article cites 28 articles, 15 of which can be accessed free at: 
 service
Email alerting
top right corner of the article 
Receive free email alerts when new articles cite this article - sign up in the box at the
 Notes   
 http://www.bmjjournals.com/cgi/reprintform
To order reprints of this article go to: 
 http://www.bmjjournals.com/subscriptions/
 go to: ThoraxTo subscribe to 
 on 11 March 2007 thorax.bmj.comDownloaded from 
Clinical profiles of Chinese patients with diVuse
panbronchiolitis
Kenneth W T Tsang, Clara G C Ooi, Mary S M Ip, Wah-kit Lam, Henry Ngan,
Eric Y T Chan, Brian Hawkins, Chu-shak Ho, Ryoichi Amitani, Eisaku Tanaka,
Harumi Itoh
Abstract
Background—DiVuse panbronchiolitis
(DPB), characterised by progressive sino-
bronchial sepsis, is well characterised in
Japanese subjects but not in other ethnic
groups. The experience with DPB in seven
Chinese patients is described and the
clinical profiles compared with those of
Japanese subjects.
Methods—Seven Chinese patients (three
women; mean (SD) age 48(18.6) years, all
never smokers) who attended a teaching
hospital centre and fulfilled the diagnostic
criteria for DPB were assessed prospec-
tively for clinical, radiological, lung
function, microbiological, and other
“characteristic” laboratory parameters.
Results—Lung function assessment
showed a typical obstructive pattern
(n = 5) and air trapping (n = 7). Typical
bronchiolar infiltration by lymphocytes
and plasma cells and accumulation of
foamy macrophages in the intraluminal
tissue were detected in open lung biopsy
specimens (n = 2). Chest radiographs and
high resolution computed tomographic
scans revealed hyperinflation, diVuse
nodules, bronchial thickening and dilata-
tion, peripheral hypoattenuation, and
bronchiolectasis. Radiological improve-
ment, manifest as a reduction in nodular
density and bronchial thickening, and
persistence of other abnormalities such as
air trapping were not accurately depicted
by the classical Nakata or Akira classifica-
tions. The other “characteristic” features
such as HLA-B54, IgG subclass defi-
ciency, raised CD4/CD8 T lymphocyte
ratio, cold haemagglutinaemia, raised
IgA, IgG, and rheumatoid factor were not
present. Treatment with erythromycin led
to excellent responses in symptoms, lung
function indices, and the radiological pic-
ture. A review of the non-Japanese cases
in the literature reveals that this absence
of typical “additional features” in DPB
might also be applicable to non-Japanese
patients.
Conclusions—We report the only series of
non-Japanese Mongoloid patients with
well characterised DPB who had unchar-
acteristic investigation profiles. This
experience should help other clinicians in
the investigation andmanagement of DPB
in non-Japanese patients.
(Thorax 1998;53:274–280)
Keywords: diVuse panbronchiolitis; chronic bronchial
sepsis; macrolides; Chinese
DiVuse panbronchiolitis (DPB) is a relatively
newly recognised idiopathic chronic progres-
sive suppurative airways disease originally
described in Japan on necropsy cases.1 It
typically presents with wheezing, chronic
bronchial sepsis, and often rapidly progresses
to respiratory failure and death before the
introduction of low dose erythromycin
therapy.2 Pathologically, thickening of the
bronchiolar wall due to infiltration by lym-
phocytes, plasma cells and histiocytes, and
peribronchiolar accumulation of foamy macro-
phages occur.3 DPB is distinct from asthma,
bronchiectasis, and chronic obstructive pulmo-
nary disease pathologically and radiologically
although some of the clinical symptoms can
overlap.4
Although DPB is not an uncommon disease
amongst Japanese subjects, only sporadic cases
have been reported in Caucasians,5–8
Koreans,9 10 Indians,11 black subjects,12 and
Hispanics.5 13 HLA-B54 is found in 63.2% of
Japanese patients with DPB (relative risk 13.3)
and has been reported in a widely quoted study
to be prevalent in 10.4% of Chinese subjects.14
This suggests that the Chinese might also be
susceptible to developing DPB.However, there
has been no systematic study on DPB in
Chinese subjects in whom it is still rarely
reported and poorly defined.4 15–18 Under-
recognition of this condition, which mimics
primary ciliary dyskinesia, bronchiectasis, and
cystic fibrosis,4 has serious consequences as
DPB is highly responsive to treatment with low
doses of erythromycin but is fatal if untreated.2
Although firmly established, the diagnostic cri-
teria for DPB were constructed according to
the characteristics of Japanese patients and
have not been validated for other ethnic
groups.4 19 We therefore report our experience
with DPB in seven well characterised Chinese
patients and compare the clinical profiles of our
patients with those of the Japanese.
Methods
PATIENT POPULATION
Between October 1994 and October 1996
seven patients (pure southern Chinese) were
diagnosed to have DPB at the Department of
Medicine, University of Hong Kong.Diagnosis
was made according to established diagnostic
criteria3–5 19 and after consultation with clini-
cians and radiologists experienced in DPB. An
informal survey through the clinical practice of
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specialist members of the Hong Kong Thoracic
Society did not reveal any other cases in Hong
Kong.
DIAGNOSTIC FEATURES
All patients presented with typical symptoms,
signs, and plain radiographic and thoracic high
resolution computed tomographic (HRCT)
features that fulfilled the clinical diagnostic cri-
teria adopted by the Japanese National
Survey19 and others as outlined in table 1.3–5 All
patients presented with chronic cough, sputum
production, and dyspnoea on exertion, while
four patients had end inspiratory crackles and
five had wheezes in their chest at initial presen-
tation. All but one patient had nasal symptoms
(obstruction and recurrent chronic discharge)
confirmed by expert otolaryngologists to be
chronic sinusitis. The other patient details are
shown in tables 2 and 3. Histological data were
available for three patients (patients 6 and 7
both had open lung and transbronchial biop-
sies and patient 1 had a transbronchial biopsy
only) which were based on the pathological
diagnostic criteria outlined by Iwata et al.4 The
most important features were the presence of
respiratory bronchiolitis and peribronchiolitis
with bronchiolar narrowing from infiltration of
mononuclear cell infiltration and/or granula-
tion tissue, and the presence of foam cells in the
bronchioles.4 The transbronchial biopsy speci-
mens were compatible with the diagnostic cri-
teria in patients 6 and 7 (also confirmed by
open lung biopsy specimens in both cases), but
were non-diagnostic in patient 1 (who declined
open lung biopsy). Patients 2 and 4 refused
whilst patients 3 and 5 were considered too
unstable to undergo any invasive procedures.
INVESTIGATION PROFILES
Lung function indices were measured using a
Sensor-Medics 2200 Lung Function package
and standard protocol as per routine clinical
practice. Nasal mucosa was obtained from the
inferior turbinate of subjects with a cytology
brush (without anaesthetic) and resuspended
in medium 199 (Flow Laboratory, Paisley,
Scotland, UK) before examination of ciliary
movement and beat frequency with a Leica
DM LB phase contrast microscope (Leica,
Wetzlar, Germany) and a MPV-COMBI
(Leica, Wetzlar, Germany) photomultiplier
system as described previously.20 Ciliated
epithelium was fixed in 2.5% glutaraldehyde
(in osmium tetroxide buVer) and embedded in
araldite for ultrastructural examination by a
trained electron microscopy technician.21
Evaluation of routine haematological indices
and renal and liver biochemical profiles; serum
immunoglobulin (Ig)G, IgA, and IgM; auto-
antibody titres (for rheumatoid factor, antinu-
clear factor, and IgG against Ro, La, Jo1, mito-
chondrial, and smooth muscle); arterial blood
gas tensions; serum IgG subclasses; lym-
phocyte subset analysis; á1-antitrypsin level;
viral titres (measles, mumps, influenza, parain-
fluenza, respiratory syncytial, adenovirus, rota-
virus, and enterovirus); blood CD4/CD8 lym-
phocyte ratio; IgG against Pseudomonas
Table 1 Diagnostic criteria for diVuse panbronchiolitis
Symptoms
Cough
Sputum production
Dyspnoea on exertion
Signs
Wheezing
Crackles
Radiology
DiVusely disseminated fine nodular shadow
Lower zone distribution
Hyperinflation
Lung function parameters
FEV1 <70% predicted or FEV1/FVC <70%
VC <80% predicted
RV >150% predicted
PaO2 <80 mm Hg (∼10.6 kPa)
Additional “characteristic but non-diagnostic” features
Chronic paranasal sinusitis
Increased serum cold haemagglutinin without raised
anti-Mycoplasma pneumoniae antibody
Increased serum IgA and IgG
Increased CD4/CD8 lymphocyte ratio
Proof of HLA Bw54 antigen
Positive rheumatoid factor
FEV1=forced expiratory volume in one second; FVC=forced
vital capacity; VC=vital capacity; RV=residual volume;
PaO2=arterial oxygen tension.
Table 2 Characteristics of patients at presentation
Patient no.
1(M) 2(M) 3(F) 4(M) 5(M) 6(F) 7(F)
Age at onset (years) 54 28 32 60 63 72 27
Age at assessment (years) 57 30 32 61 64 73 33
No. of months on treatment 28 14 4 4 4 3 2
Nasal symptoms (years) 30 15 15 None 50 15 10
Physical examination Wheezes Normal Wheezes/crackles Wheezes/crackles Wheezes/crackles Wheezes/crackles Wheezes
Sputum pathogen H influenzae P aeruginosa Commensals H influenzae P aeruginosa Mycobacterium
tuberculosis
H influenzae
Travel history to Japan Nil 15 years before Nil Nil 11 years before Nil 10 years
before
Medication Atenolol Nil Nil Nil Nil Nil Nil
Concurrent illness Hypertension Renal transplant Nil Nil Cor pulmonale Neurofibroma T8 Nil
Ciliary beat frequency
(12–16 Hz)* 12 12.1 9.7 14.1 14.1 12.2 10.1
Ciliary ultrastructure Normal Normal Normal Normal Normal Normal Normal
Serum IgA (90–450 mg/dl)* 268 224 614 420 368 365 465
CD4/CD8 ratio (0.63–3.24)* 1.98 0.57 3.55 3.7 1.58 0.78 1.88
Cold haemagglutinin Negative Negative Negative Negative Negative Negative Negative
IgG againstM pneumoniae Negative Negative Negative Negative Negative Negative Negative
HLA typing A2,B5,B60, A2,A33,B17, A24,A11,B13, A2,A24,B55 A24,B60,B35 A2,A11,B60 A24,A11,B27,
DR9,DR11 B55,DR15,DR3 B51,DR9,DR16 B70,DR9,DR16 DR9,DR12 DR8,DR9 DR12,DR15
Histological examination TBB Nil Nil Nil Nil TBB+OLB TBB+OLB
TBB and OLB=transbronchial and open lung biopsies, respectively.
*Normal range for data.
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pseudomallei, Legionella pneumophilia, Chlamy-
dia psittaci, Mycoplasma pneumoniae, and
human adult T cell leukaemia virus (HTLV-1);
Aspergillus precipitins; serum cold haemagglu-
tinin; complements 3 and 4; sputummicrobiol-
ogy (routine aerobic and anaerobic, mycobac-
terial and fungal cultures), and full human
leucocyte antigen (HLA) typing were per-
formed at the Biochemistry, Haematology,
Clinical Immunology, Microbiology, and Tis-
sue Typing departments of the University of
Hong Kong using routine methods. Density
gradient sedimentation with Lymphoprep (Ny-
comed, Oslo, Norway) and ammonium chlo-
ride were used to remove the mononuclear and
red cells in leucocyte-rich concentrate obtained
from heparinised blood mixed with 6% dex-
tran. Cytospins of granulocytes were fixed in
absolute alcohol at 4°C for five minutes. Serum
samples were diluted (1:20) in phosphate buV-
ered saline and anti-neutrophil cytoplasmic
antibody (ANCA) binding was detected by
rabbit anti-human IgG-FITC conjugate
(Dako, Glostrup, Denmark).22
RADIOLOGICAL ASSESSMENT
All seven patients underwent thoracic HRCT
scanning at the time of diagnosis and re-
assessment (after 8.6 (9.4) months of erythro-
mycin therapy) and were scanned in the supine
position (scan thickness 1 mm or 1.5 mm and
slice interval 10 mm). Expiratory scans used to
evaluate air trapping were obtained for two
patients before and seven patients after eryth-
romycin therapy. The HRCT scan and plain
postero-anterior films were analysed by three
experienced radiologists who resolved diVer-
ences by consensus. Each lung was divided into
three zones: upper (apex to carina), middle
(carina to venous confluence), and lower
(venous confluence to bases). Six lung zones
were therefore evaluated individually for each
patient. HRCT scans were graded as described
previously by Akira et al23: type 1, nodules asso-
ciated with bronchovascular branchings; type
2, nodules branching in appearance (“tree-in-
bud”); type 3, nodules connected to ring-
shaped or ductal opacities (bronchiolectasis);
and type 4, dilatation of proximal terminal
bronchioles and bronchi (predominantly at the
peripheral airways).23 24 Distribution (diVuse or
localised), symmetry, profusion of nodules, and
areas of hypoattenuation and air trapping (on
expiratory HRCT scans) were also assessed.
Grading for nodular profusion, hypoattenua-
tion, and air trapping was made according to
the extent of involvement in each lung zone as:
0 (normal), 1 (<25% of lung zone involve-
ment), 2 (>25% but <50%), and 3 (>50%).
Bronchial dilatation was similarly graded by
comparing bronchial calibre with that of the
accompanying artery: 0 (normal bronchial
calibre), 1 (<1.5 times calibre of accompanying
artery), 2 (>1.5 but <2.0 times), and 3 (>2
times). Bronchial thickening was graded as 1
(mild), 2 (moderate), and 3 (severe). For each
Table 3 Investigation profiles at presentation and re-assessment
Patient no.
1 2 3 4 5 6 7
Blood leucocyte count (×109/ml) 11.7 (11.8) 7.6 (6.5) 8.3 (7.2) 9.6 (7.0) 13.9 (9.1) 6.1 (6.4) 9.0 (5.8)
Erythrocyte sedimentation rate (mm/h) 12 (20) 37 (2) 63 (54) 86 (3) 45 (32) 48 (6) 26 (39)
C reactive protein (<1 mg/dl) <0.3 (<0.3) <0.3 (<0.3) 1.0 (<0.3) 6.4 (<0.3) 0.6 (<0.3) <0.3 (<0.3) <0.3 (<0.3)
Auto-antibodies Negative Negative Negative Negative Negative Negative Negative
Complement 3 and 4 Normal Normal Normal Normal Normal Normal Normal
24 hour sputum production
(ml/24 h) 60 (20) 30 (0) 10 (0) 20 (0) 30 (20) 20 (5) 100 (50)
FEV1 (% predicted) 23 (47) 84 (142) 41 (64) 57 (98) 22 (25) 53 (54) 44 (86)
FVC (% predicted) 61 (92) 95 (143) 52 (83) 67 (114) 35 (42) 45 (109) 101 (87)
FEV1/FVC 29 (39) 74 (83) 69 (77) 63 (63) 47 (60) 80 (44) 38 (71)
RV (% predicted) 212 (180) 147 (116) 167 (131) 270 (164) 101 (90) 144 (156) 164 (185)
VC (% predicted) 64 (76) 93 (140) 66 (110) 70 (119) 37 (55) 39 (97) 96 (70)
RV/TLC 58 (48) 38 (24) 57 (36) 64 (37) 57 (55) 62 (42) 56 (55)
KCO (% predicted) 84 (101) 101 (82) 105 (106) 111 (90) 101 (100) 98 (138) 140 (138)
PaO2 (kPa)* 8.3 (10.2) 12 (11.4) 9.3 (10.3) 8.2 (10.5) 8.0 (9.8) 8.1 (10.0) 9.0 (11.0)
Data shown are measurements made at presentation and re-assessment (in parentheses).
*Normal range for arterial blood gases when breathing room air 10.6–14 kPa.
FEV1=forced expiratory volume in one second; FVC=forced vital capacity; RV=residual volume; VC=vital capacity; TLC=total lung capacity; KCO=carbon monox-
ide transfer coeYcient; PaO2=arterial oxygen tension.
Table 4 Radiological assessment at presentation and re-assessment
Patient no.
1 2 3 4 5 6 7
Nakata radiographic grading23 III (III) II (II) III (III) IV (II) IV (IV) III (III) II (II)
Akira HRCT grading22 29 3 (4) 3 (2) 3 (3) 3 (2) 4 (4) 2 (2) 3 (3)
Nodular profusion, overall score 2 (0.7) 1.8 (0.8) 2 (1.7) 2.3 (1.3) 2.3 (2) 2.7 (1.4) 1.7 (1.2)
Nodular symmetry Asymmetrical Asymmetrical Symmetrical Symmetrical Symmetrical Symmetrical Symmetrical
Nodular distribution DiVuse DiVuse DiVuse DiVuse DiVuse DiVuse DiVuse
Airway dilatation, overall score 1.5 (1.8) 1.0 (0.8) 1.1 (0.8) 0.8 (0.3) 2.0 (2.0) 1.6 (1.0) 0.7 (0.7)
Airway thickening 1.5 (1.3) 1.0 (0.8) 1.3 (0.7) 0.7 (0.3) 1.3 (1.3) 2.0 (0.4) 1.7 (1.3)
Hypoattenuation, overall score 2 (3) 0.2 (0.2) 0.8 (1.2) 0.2 (0.2) 1.7 (2.7) 1.7 (2.6) 1.0 (1.0)
Air trapping,* overall score NP (1.2) 1.3 (1) NP (1.3) NP (1.0) 2.0 (2.7) NP (2.6) NP (0.7)
Data shown are assessments made at presentation and re-assessment (in parentheses).
*Assessment made at expiratory HRCT scanning of the thorax.
NP=not performed.
Please refer to text for the scoring systems.
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of these features an overall score was obtained
by dividing the sum of the scores from all lung
zones by six.
Chest radiographs corresponding in time to
the HRCT scans were graded from types I to V
as described by Nakata et al.24 Types I, II, III,
IV, and V were assigned when there was
overinflation without nodular shadows, dis-
seminated small nodular shadows confined to
one lung, small nodular shadows in both lungs,
ring-shaped or tramline shadows in the lower
lungs with nodular shadows, and large ring-
shaped and nodular shadows, respectively.
Results
DEMOGRAPHIC DATA
The mean (SD) ages at onset of symptoms and
at initial assessment were 48 (18.6) and 50
(17.8) years. None of the seven patients (three
women) had ever smoked cigarettes and they
received treatment with erythromycin (250 mg
twice daily) for 8.6 (9.4) months before
re-assessment. Three patients had travelled to
Japan 15, 11, and 10 years before the onset of
symptoms (table 2).
CLINICAL FEATURES
Six patients had had nasal symptoms (obstruc-
tion and rhinorrhoea) for a mean of 22.5 (15.1)
years. All seven patients presented with copious
purulent sputum production (38.6 (31.2) ml/
24 hours), cough, and dyspnoea on exertion.
At the initial assessment six patients were
found to have wheezes and five had crackles in
their chest on physical examination. After 8.6
(9.4) months of treatment with erythromycin
the presenting symptoms of dyspnoea on exer-
tion, cough, sputum production, and nasal
symptoms improved in all seven patients. The
mean sputum volume reduced to 13.6
(18.4) ml/24 hours and patients 2, 3, and 4 had
no further sputum production at re-assessment
(table 3). Examination of the chest revealed no
further wheezing in five and persistence of
crackles in five patients.
INVESTIGATION PROFILES
All the patients underwent the investigation
profiles listed above and repeated measure-
ments were made on some selected parameters
as shown in table 3. At initial presentation the
mean (SD) forced expiratory volume in one
second (FEV1), forced vital capacity (FVC),
residual volume (RV), vital capacity (VC), car-
bon monoxide transfer coeYcient (KCO), and
arterial oxygen tension (PaO2) were 46.3
(21.4)%, 65.1 (24.8)%, 172.1 (54.4)%, 66.4
(23.2)%, 105.7 (17.2)%, and 9.0 (1.4) kPa,
respectively, which changed to 73.7 (38.7)%,
95.7 (31.3)%, 146 (35.0)%, 95.3 (30.0)%,
107.9 (22.1)%, and 10.5 (0.6) kPa after eryth-
romycin therapy. Tests for ciliary beat move-
ment and frequency, ciliary ultrastructure,
HLA typing, á1-antitrypsin, viral titres, IgG
against P pseudomallei, L pneumophilia, C
psittaci,M pneumoniae, and HTLV-1, Aspergil-
lus precipitins, complements 3 and 4, and rou-
tine haematological and biochemical indices
were negative or normal at initial presentation.
Serum IgA and IgG3 levels were persistently
raised in two and three patients, respectively,
although the levels of other immunoglobulins
were normal. Antinuclear factor was positive in
six patients and anti-smooth muscle in two,
while anti-dsDNA, anti-extractable nuclear
antigen, rheumatoid factor, and anti-mito-
chondrial antibodies were negative in all
patients. ANCA (cytoplasmic) was positive in
six patients, none of whom had anti-proteinase
Figure 1 Plain chest radiograph in case 1 showing
multiple diVuse nodules in both lung fields with a
predominance at the right hemithorax. There was also
hyperinflation consistent with air trapping.
Figure 2 Thoracic high resolution computed tomographic scans in case 1 showing (A) centrilobular nodules with
tree-in-bud appearance in the lower lobes and bronchial thickening and dilatation at the onset of diVuse panbronchiolitis,
and (B) significant resolution of the nodular densities after starting treatment with erythromycin.
DiVuse panbronchiolitis in Chinese patients 277
 on 11 March 2007 thorax.bmj.comDownloaded from 
III antibody. Lymphocyte subset distribution
was normal in three patients but the remaining
four displayed an increase in CD4 T cells, a
decrease in CD3 T cells, an increase in CD3
and CD8 T cells, and a decrease in CD3 and
CD8 T cells, respectively. The CD4/CD8 ratio
was raised in two patients, reduced in one, and
normal in four patients.
P aeruginosa was isolated from the sputum of
two patients and Haemophilus influenzae from
three patients at initial presentation. The
remaining case had no identifiable pathogen in
her sputum. The sputum of patient 6 yielded
only Mycobacterium tuberculosis on culture
(negative Ziehl-Neelson staining), although
repeated bronchoscopic, bronchial and trans-
bronchial biopsies and bronchoalveolar lavage
had not yielded any other evidence of tubercu-
lous infection (endobronchial and parenchy-
mal). In addition, a two month supervised
course of rifampicin, isoniazid, ethambutol,
and pyrazinamide did not alter her symptoms
or produce any improvement in lung function
or radiology (HRCT and plain radiography).
This was followed by open lung biopsy which
confirmed the diagnosis of DPB.
RADIOLOGICAL ASSESSMENT
At the initial assessment nodular distribution
with lower lobe predominance was bilateral
and diVuse in all except two cases, in whom it
was asymmetrical (table 4). After treatment
with erythromycin there was an overall im-
provement in both bronchial thickening and
dilatation, but not in hypoattenuation of the
peripheral areas. Air trapping was confirmed
on expiratory scans in only two cases at initial
presentation and in all seven cases after eryth-
romycin treatment. The serial Akira and
Nakata classifications remained unchanged in
four and six patients, respectively, and did not
appear to reflect the reduction in nodular per-
fusion which was the most significant response
to treatment (figs 1 and 2).
Discussion
All our patients presented with typical chronic
sinobronchial sepsis and most had persistence
of P aeruginosa orH influenzae in their sputum,
characteristic radiological features, and excel-
lent clinical and radiological response to
macrolide therapy (tables 1–4). However, our
cases diVer from the Japanese patients (table 1)
in several respects, primarily the absence of
HLA-B54 type. The Chinese patient men-
tioned briefly by Iwata et al did not possess
HLA-B54 but shared a common feature with
most of our patients in possessing HLA-A2.4
The 10% prevalence of HLA-54 in Chinese
subjects quoted in the literature14 does not
agree with our finding of a prevalence of 3% in
patients from southern China.25 If HLA-B54
has a pathological role in DPB, then this low
incidence of HLA-54 would explain the
relative scarcity of DPB in the Chinese popula-
tion, in addition to the probable underdiagno-
sis and reporting. Five of the seven patients in
this series had HLA-DR9 compared with
29.2% in the normal population in Hong
Kong. Although the number of patients tested
is small, our preliminary results suggest that
future patients should also be tested for HLA-
DR9 and HLA-A2. Two of our patients also
had HLA-B55, which has also been reported to
be increased in a Japanese study.14
Three of our cases had raised IgG3 levels but
IgG4 levels were normal, whereas 30.8% of
Japanese patients were reported to have IgG4
deficiency.26 The other “atypical” features
include normal or low CD4/CD8 lymphocyte
ratio in five patients, absence of raised serum
IgA in five, and absence of raised serum IgG,
cold haemagglutinin and rheumatoid factor in
seven patients.5 A review of the cases in the lit-
erature of DPB in non-Japanese subjects
revealed a total of 19 Mongoloid (14 Chinese
and five Koreans) and 13 non-Mongoloid cases
who generally had not been systematically
evaluated.4–8 10 12 13 16–18 27 Of these, HLA-B54
was detected in only two cases in the former
and either not checked or not detected in the
latter group. In addition, raised levels of cold
haemagglutinin were found in two Hispanic
patients but not in the rest of the aforemen-
tioned 32 cases.5 13 The other investigation
profiles that were considered to be characteris-
tic and helpful in the diagnosis (table 1),
including CD4/CD8 lymphocyte ratio, serum
IgA level, IgG subclass analysis, and M
pneumoniae serology, were not evaluated in
these non-Japanese patients. Our results sug-
gest that these “additional” features (table 1)
might not be applicable in the diagnosis of
DPB in non-Japanese patients. The finding of a
positive ANCA in six of our patients is also
interesting and needs confirmation by other
workers, as this has not been reported previ-
ously in DPB.
The value of HRCT scans in assessing small
airways disease in DPB is clear and is substan-
tiated by pathological-radiological
correlation.23 28 29 This experience, however, is
limited to Japan, largely due to the relative
confinement of DPB to that country. Periph-
eral areas of hypoattenuation on HRCT
scanning29–31 are a non-specific indicator of air
trapping and reflect an underlying hyperinfla-
tion caused by narrowing of the small airways.29
In the only other series of patients with DPB
followed up by HRCT scanning after treat-
ment with erythromycin there was an improve-
ment in nodular profusion but not airway dila-
tation and peripheral hypoattenuation.30 In
contrast, our findings suggest that there was
partial reversibility in bronchiolar dilatation in
our patients, although no corresponding im-
provement in the peripheral areas of hypo-
attenuation was evident. This might be due to
selective and more severe injury to the periph-
eral airways resulting in sustained distal air
trapping, whilst the less aVected central larger
airways recovered with erythromycin treat-
ment. However, in agreement with Akira et al,30
there was a universal reduction in nodular pro-
fusion in all our patients after erythromycin
treatment. This important feature in the radio-
logical follow up of these patients, which
appears to parallel the improvement in lung
function and clinical improvement, could not
be accurately represented in the Nakata
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classification.28 Our study also highlights the
relative insensitivity of plain radiography com-
pared with HRCT scanning in assessing
disease activity, particularly in small airway
pathology. The usefulness of the Nakata radio-
graphic and Akira HRCT classifications in this
study therefore appears to be limited.
As with Japanese patients, our patients
responded very well in terms of lung function
indices, blood oxygenation, symptomatic relief,
sputum production, and radiological evalua-
tion to low dose, long term treatment with
erythromycin.2 Whilst the eYcacy of mac-
rolides in treating DPB is well established, the
mechanism(s) is still largely unknown. One
possible mechanism is the reduction of pulmo-
nary levels of interleukin 8 and leukotriene B4
which are potent chemotactic agents.32 33 This
leads to a reduction in neutrophil influx into
the airways and alveolar space34 which is known
to cause airway destruction in chronic bron-
chial sepsis by various processes such as the
release of human neutrophil elastase.35 36 It is
also possible that erythromycin interferes with
the formation of P aeruginosa biofilms which
are important in its persistence in the
airways.37 38 Until the precise mechanism is
known, more specifically targeted treatment
cannot be planned other than empirical
treatment with macrolides. There appears to be
a “class eVect” in that most of the available
macrolides including erythromycin, clarithro-
mycin, roxithromycin, and azithromycin, are
eYcacious in DPB.39 For resistant cases recent
in vitro and clinical evidence suggests that
inhalation of indomethacin and oxitropium
bromide might be eVective in reducing sputum
production.40 41
Interestingly, three of our patients had
travelled to Japan prior to the onset of
symptoms, similar to the Hispanic man who
developed DPB after extensive travels to Japan
and South East Asia.13 However, the long
interval between the journey to Japan and the
onset of symptoms makes an aetiological link-
age very unlikely in our patients. As in the cases
in the Japanese literature, there was no identifi-
able aetiology for the onset of chronic bron-
chial sepsis or DPB in our patients. Our inves-
tigations have also eVectively excluded all the
known diVerential diagnoses for DPB includ-
ing primary ciliary dyskinesia, bronchiectasis,
chronic bronchitis and emphysema, bronchi-
olitis obliterans, cystic fibrosis (not known to
occur in Chinese), Wegener’s granulomatosis,
malignant lymphoma, and bare lymphocyte
syndrome.4
Whilst we have demonstrated characteristic
features of DPB in all our cases, only four
patients were examined histologically for fea-
tures of DPB. Open lung biopsy specimens of
patients who fulfilled the clinical diagnostic
criteria for DPB might very occasionally show
unclassified bronchiolitis and bronchiolecta-
sis.42 However, in most instances the pathologi-
cal changes in DPB correlate well with HRCT
features29 and HRCT scanning is advocated
and frequently used as the diagnostic tool in
this condition,43 especially in Japan where
clinicians and radiologists have considerable
relevant experience. In practice, most patients
with DPB in Japan are routinely diagnosed
using high quality thoracic HRCT scans. The
clinical and radiological response to erythro-
mycin also gives very good circumstantial
evidence to support the diagnosis of DPB.
We have reported seven cases of DPB who,
despite typical clinical features, appear to have
diVerent investigation profiles from their Japa-
nese counterparts. More experience needs to
be gathered on non-Japanese patients to evalu-
ate further the clinical characteristics of this
macrolide responsive but otherwise progressive
idiopathic pulmonary disease.
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